Trial Profile
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Tradipitant for Functional Dyspepsia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2024
Price :
$35
*
At a glance
- Drugs Tradipitant (Primary)
- Indications Dyspepsia
- Focus Therapeutic Use
- Sponsors Vanda Pharmaceuticals
- 05 Apr 2024 Status changed from not yet recruiting to recruiting.
- 20 Dec 2022 New trial record